HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Dong Hu Selected Research

2-Amino-5-phosphonovalerate (2 Amino 5 phosphonovalerate)

11/2013Ca2+ /calmodulin-dependent protein kinase II in spinal dorsal horn contributes to the pain hypersensitivity induced by γ-aminobutyric acid type a receptor inhibition.
5/2011GABAergic disinhibition induced pain hypersensitivity by upregulating NMDA receptor functions in spinal dorsal horn.
7/2009Peripheral inflammation increased the synaptic expression of NMDA receptors in spinal dorsal horn.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Dong Hu Research Topics

Disease

28Pain (Aches)
09/2021 - 02/2006
11Hypersensitivity (Allergy)
09/2021 - 05/2011
10Inflammation (Inflammations)
05/2021 - 07/2009
10Hyperalgesia
01/2020 - 05/2003
1Lymphoma (Lymphomas)
09/2021
1Major Depressive Disorder (Major Depressive Disorders)
01/2019
1Neuralgia (Stump Neuralgia)
05/2018
1Periodontitis
10/2017
1Alzheimer Disease (Alzheimer's Disease)
10/2016
1Tetanus
02/2004

Drug/Important Bio-Agent (IBA)

11N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2019 - 07/2009
10Freund's AdjuvantIBA
10/2020 - 07/2013
5Formaldehyde (Formol)FDA Link
05/2021 - 01/2018
5Tyrosine (L-Tyrosine)FDA Link
07/2019 - 11/2011
4Peptides (Polypeptides)IBA
01/2020 - 02/2015
4Small Interfering RNA (siRNA)IBA
01/2019 - 01/2018
4N-Methylaspartate (NMDA)IBA
03/2015 - 07/2009
3UbiquitinIBA
09/2021 - 01/2019
3Analgesics (Analgesic Drugs)IBA
07/2019 - 10/2015
3Protein Tyrosine PhosphatasesIBA
01/2018 - 07/2013
3BicucullineIBA
03/2015 - 05/2011
32-Amino-5-phosphonovalerate (2 Amino 5 phosphonovalerate)IBA
11/2013 - 07/2009
2Glycine Receptors (Glycine Receptor)IBA
05/2021 - 10/2020
2Adenosine A1 ReceptorIBA
10/2020 - 11/2017
2neurabinIBA
11/2019 - 10/2015
2Proteins (Proteins, Gene)FDA Link
05/2018 - 05/2003
2NR2B NMDA receptorIBA
03/2015 - 02/2014
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
02/2014 - 11/2013
2KN 93IBA
11/2013 - 02/2004
2Diazepam (Valium)FDA LinkGeneric
05/2011 - 02/2006
1Ligases (Synthetase)IBA
09/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2021
1Protein Kinase CIBA
05/2021
1StrychnineIBA
05/2021
1Vesicle-Associated Membrane Protein 2 (VAMP2)IBA
01/2020
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2020
1SNARE Proteins (SNAREs)IBA
01/2020
1Glutamic Acid (Glutamate)FDA Link
07/2019
1CarrageenanIBA
07/2019
1Antidepressive Agents (Antidepressants)IBA
01/2019
1Metabotropic Glutamate 5 ReceptorIBA
01/2019
1gaboxadol (THIP)IBA
10/2018
1Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
05/2018
1Streptozocin (Streptozotocin)FDA Link
05/2018
1neuroligin 1IBA
01/2018
1Adenosine (Adenocard)FDA LinkGeneric
11/2017
1Thrombospondin 1IBA
10/2017
1CytokinesIBA
10/2017
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2017
1diallyl disulfide (diallyl disulphide)IBA
10/2016
1PaxillinIBA
03/2016
1Protein Phosphatase 1IBA
10/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2015
1Focal Adhesion Protein-Tyrosine KinasesIBA
06/2015
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2015
1Glutamate Receptors (Glutamate Receptor)IBA
03/2015
1Calcium-Calmodulin-Dependent Protein KinasesIBA
02/2014
1Adrenergic Receptors (Adrenergic Receptor)IBA
02/2014
1Clonidine (ST 155)FDA LinkGeneric
02/2014
1AMPA Receptors (AMPA Receptor)IBA
11/2013
1Aminobutyrates (Aminobutyric Acid)IBA
11/2013
1GYKI 52466IBA
11/2013
1Vanadates (Orthovanadate)IBA
07/2013
1bisperoxo(1,10- phenanthroline)oxovanadate(1- )IBA
07/2013
16-pyruvoyltetrahydropterin synthase (PTPS)IBA
07/2013
1ifenprodilIBA
11/2011
1GABA-A Receptor AntagonistsIBA
05/2011
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
05/2011
1protein kinase modulatorIBA
05/2011
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2011
1AnisomycinIBA
05/2003
1Protein Synthesis InhibitorsIBA
05/2003
1Cycloheximide (Cicloheximide)IBA
05/2003

Therapy/Procedure

3Spinal Injections
07/2013 - 05/2011
2Analgesia
05/2018 - 11/2017
1Therapeutics
05/2021
1Intraperitoneal Injections
05/2018